Russell Kowalczyk (Bo)

Bo Kowalczyk has extensive experience in the biotech and pharmaceutical industry. Russell (Bo) currently holds the position of Chief Commercial Officer at ApiJect, where they are responsible for the global commercialization efforts of their pre-filled single-use syringe. Prior to ApiJect, Bo served as the VP of Sales, Development, and Manufacturing for North America at Syngene International Limited. Russell (Bo) also held leadership roles at Eurofins Bioanalytical Services, AIT Bioscience, SGS Life Sciences, ABC Labs, Nanophase Technologies, deCODE Chemistry, and MediChem Research. Throughout their career, Bo has demonstrated expertise in business development, sales, and strategic account management.

Russell (Bo) Kowalczyk completed their education chronologically as follows:

From 2005 to 2009, they attended the University of Illinois Chicago and earned an MBA degree with a focus on Management and Marketing.

Between 1997 and 2001, they enrolled in the Illinois Institute of Technology and obtained a M.Sc degree in Chemistry.

From 1988 to 1992, they attended DePaul University, although no specific degree or field of study was mentioned.

Lastly, from 1984 to 1988, Kowalczyk attended Eisenhower High School, where they completed their secondary education. No specific degree or field of study was specified during this time.